Intravenous immunoglobulins versus plasmapheresis in older patients with Guillain-Barre syndrome.
Rana
S S
SS
Rana
S
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000368:Aged; D001369:Axons / Q000502:physiology; D001778:Blood Coagulation Disorders / Q000209:etiology; D003711:Demyelinating Diseases / Q000503:physiopathology / Q000628:therapy; D004576:Electromyography; D020275:Guillain-Barre Syndrome / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007022:Hypotension / Q000209:etiology; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D009431:Neural Conduction; D010956:Plasmapheresis / Q000009:adverse effects; D012189:Retrospective Studies
D000276:Adjuvants, Immunologic; D016756:Immunoglobulins, Intravenous